Sharon Dell, MD, FRCPC
University of British Columbia; Vancouver, BC

Session Description

Children’s interstitial lung disease (chILD) is rare but associated with the highest mortality of all pediatric chronic lung diseases. Modern genome sequencing techniques have revealed novel mechanisms of disease in chILD. Multicenter clinical research networks have provided the infrastructure for driving advances in this field. This session will briefly review our current understanding of the basic epidemiology, diagnosis and management of children’s interstitial lung disease (chILD) and then focus on recent literature advancing the field.

Learning Objectives

At the end of this presentation, attendees will be able to:

  • Recognize clinical presentations of chILD in infancy and older children
  • Know when to order genetic testing to diagnose chILD
  • Recognize new chILD (kids) on the block

CanMEDS Roles: Collaborator, Health Advocate, Medical Expert, Scholar